Projects per year
- 1 - 50 out of 139 results
Search results
-
(36MTHS)Birmingham Cancer Research UK Centre (Clinical Training Account)
1/10/11 → 31/07/15
Project: Research
-
(36MTHS)The Role of the Bone Marrow Fibroblast as a Determinant of Tumour Cell Survival in Paraproteinaemia
1/10/09 → 31/05/14
Project: Research
-
(60MTHS)CRUK Clinical Trials Unit, University of Birmingham
Kearns, P., Billingham, L., Bowden, S., Craddock, C., Doran, J., James, N., Moss, P., Palmer, D., Porfiri, E., Rea, D. & Steven, N.
1/10/08 → 30/09/13
Project: Research
-
(60MTHS)Renewal of ECMC at Birmingham
Tselepis, C., Middleton, G., Craddock, C., Moss, P., Steven, N. & Morton, D.
1/04/12 → 31/03/17
Project: Research
-
(AZTEC) A Phase II study of the use of Azacitidine for the treatment of patients with chronic garft-versus-host-disease who have failed therapy with corticosteroids
Moss, P. & Craddock, C.
1/03/15 → 31/12/19
Project: Research
-
A Biological and Epidemiological Study of the Clinical Significance of Cytomegalovirus Infection in Elderly Donors
13/09/10 → 12/09/13
Project: Research
-
Adoptive T Cell Immunotherapy Therapy for Adenovirus Infection in Transplant Patients
Moss, P., Cobbold, M. & Mautner, V.
1/04/07 → 31/08/10
Project: Research Councils
-
A multi-centre randomised controlled trial examining the effects of temporarily pausing Bruton Tyrosine Kinase inhibitor therapy to coincide with SARS-CoV-2 vaccination and its impact on immune responses in patients with Chronic Lymphocytic
Parry, H., Richter, A. & Moss, P.
NIHR EVALUATION, TRIALS AND STUDIES COORDINATING CENTRE
1/08/22 → 31/07/24
Project: Other Government Departments
-
A Multi-Disciplinary Approach to Understanding the Immunological Basis and Potential Prevention of Graft versus Host Disease
Moss, P., Malladi, R., Craddock, C., Pratt, G., Smith, D. & Tino, P.
1/10/13 → 30/06/18
Project: Research Councils
-
An Investigation into T Cell Function of Patients Receiving Tyrosine Kinase Inhibitors
Craddock, C., Moss, P. & Piper, K.
1/09/09 → 28/02/13
Project: Research
-
A Randomized Phase II Trial CMV Specific Adoptive Immunotherapy After Stem Cell Transplantation
Moss, P., Chen, F., Cobbold, M. & Craddock, C.
1/02/09 → 31/08/14
Project: Research
-
ATM and Related Pathways as Therapeutic Targets in Chronic Lymphocytic Leukaemia and other Lymphoid Malignancies
Stankovic, T., Moss, P., Stewart, G. & Taylor, M.
1/01/11 → 14/02/12
Project: Research
-
ATM Pathways in CLL: The Development of Targeted Treatment
Stankovic, T., Moss, P. & Taylor, M.
BLOODWISE, KUDOS PHARMACEUTICALS LTD
1/01/06 → 31/12/10
Project: Research
-
A UK underpinning platform to study immunology and immunopathology of COVID-19:The UK Coronavirus Immunology Consortium
Duggal, N., Zuo, J., Moss, P., Long, H., Lord, J., Taylor, G. & Wraith, D.
20/08/20 → 31/10/22
Project: Research Councils
-
-
Birmingham Cancer Research UK Centre: Academic Chairs & Strategic Appointments
1/07/09 → 30/09/14
Project: Research
-
Birmingham Cancer Research UK Centre:Clinical Training Account 2013 intake (Linked to 17418)
1/10/13 → 30/09/16
Project: Research
-
Birmingham Cancer Research UK Centre: Non Clinical Training Account - 2010 Intake
1/10/10 → 30/09/14
Project: Research
-
-
Birmingham Cancer Research UK Centre (Clinical Training Account) (linked to RCPV15028)
1/09/10 → 31/08/14
Project: Research
-
Birmingham ECMC
Beggs, A., Moss, P., Kearns, P., Craddock, C., Nankivell, P., Willcox, B., Morton, D., Middleton, G., Khoja, L., Drayson, M., Tomlinson, I., Steven, N., Taylor, M., Watts, C. & Mehanna, H.
1/04/17 → 31/03/23
Project: Research
-
-
-
Cancer Research UK Birmingham Centre. See Also RCPV20624
Kearns, P., Willcox, B., Lee, S., Middleton, G., Moss, P. & Morton, D.
1/04/17 → 31/12/24
Project: Research
-
Cellular Immunity to Herpesvirus Infection: Studies with Epstein-Barr Virus and Human Cytomegalovirus
1/09/05 → 31/08/10
Project: Research Councils
-
Cellular Immunity to Herpesvirus Infections: Studies with Epstein-Barr Virus (EBV) and Human Cytomegalovirus (CMV)
Rickinson, A., Moss, P. & Rowe, M.
1/09/10 → 31/08/15
Project: Research Councils
-
-
-
-
CO-CONNECT - COVID-Curated and Open Analysis and Research Platform
18/10/20 → 17/04/22
Project: Research Councils
-
Collaboration between University of Birmingham and Crescendo Biologics
9/01/17 → 8/01/19
Project: Industry
-
COVID-19 Immunity – National Core Study (IMM-NCS) April 2021-March 2022
Moss, P., Pearce, H., Zuo, J. & Parry, H.
1/04/21 → 31/03/23
Project: Research
-
-
-
-
DCS - An Investigation to Enhance Immunity to Influenza in Elderly Individuals Through Reversal of the Immune Senescence
Moss, P. & McManus, R.
1/01/11 → 30/06/16
Project: Research Councils
-
Determination of Susceptibility Genes for the Development of B- Cell Chronic Lymphocytic Leukamia
1/01/99 → 31/12/01
Project: Research
-
Development of a Fully Integrated Service for Sequencing-Based Tumour Profiling Including Data Interpretation and Commercialisation of Assay Panel Kit Products
1/12/11 → 30/11/14
Project: Other Government Departments
-
Development of the Therapeutic Potential of Cancer Testis Antigen Specific T Cells in the Management of Plasma Cell Dyscrasias
Moss, P. & Pratt, G.
BLOODWISE, UHB CHARITABLE FUNDS
1/02/09 → 30/06/11
Project: Research
-
Direct Selection and Adoptive Transfer of Cytomegalovirus-specific Cytotoxic T Cells into Patients Undergoing Stem Cell Transplantation.
Moss, P. & Cobbold, M.
1/04/00 → 31/03/03
Project: Research Councils
-
Does CMV Reactivation Cause Functional Impairment of CMV Specific CD4+ T-Cells? The Potential for Valaciclovir to Prevent CMV-Mediated Adverse Modulation of the Immune System in Patients with ANCA-Associated Vasculitis
Moss, P., Harper, L. & Morgan, M.
THE WELLCOME TRUST, VASCULITIS UK
1/08/12 → 31/10/19
Project: Research
-
ECMC Application for Support of Translational Cancer Research at Birmingham
Cancer Research UK, UHB CHARITABLE FUNDS
1/04/07 → 31/03/14
Project: Research
-
Enhancement of the GvL Effect by Targeted Immunotherapy to Lineage Restricted Minor Histocompatibility Antigens
Moss, P., Rickinson, A. & Young, L.
1/05/99 → 31/03/05
Project: Research
-
From immune suppression to immunotherapy: the function and clinical significance of the immune response to pancreatic cancer
Moss, P., Middleton, G. & Cazier, J.
1/07/16 → 31/01/23
Project: Research
-
Generation of Soluble Peptide HLA Class II Complexes for Direct Visualisation of Antigen Specific CD4+T Cells
1/09/98 → 31/08/00
Project: Research
-
Immune Recognition and Regulation by the Leukocyte Immunoglobulin-Like Receptor Family
1/06/04 → 4/07/07
Project: Research
-
Immunomodulation of B-Cell Chronic Lymphocytic Leukaemia by Gene Transfer
Moss, P. & Mautner, V.
8/04/99 → 7/11/02
Project: Research Councils
-
Immunotherapeutic Targeting of Pancreatic Cancer
Contino, G., Croft, W., Moss, P., Middleton, G. & Pearce, H.
9/09/21 → 8/09/24
Project: Industry